Results 71 to 80 of about 17,707 (220)

Evidence for the intracellular accumulation of anandamide in adiposomes

open access: yes, 2008
Anandamide is a lipid messenger that carries out a wide variety of biological functions. It has been suggested that anandamide accumulation involves binding to a saturable cellular component.
ODDI, Sergio   +7 more
core   +2 more sources

Δ9 Tetrahydrocannabinol and cannabis extracts differentially improve adipoinsular dysfunction in diet‐induced obesity

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend THC and extract administered to diet‐induced obese mice reduced body weight and fat storage. Extract, but not THC, improved glucose clearance by a mechanism that may include restoring adipoinsular function. Abstract Diet‐induced obesity (DIO) is associated with dysregulated adipoinsular axis and endocannabinoid system (eCBS ...
Bryant Avalos   +7 more
wiley   +1 more source

Anandamide increases swelling and reduces calcium sensitivity of mitochondria

open access: yes, 2009
The endocannabinoid anandamide alters mitochondria-dependent signal transduction, thus controlling key cellular events like energy homeostasis and induction of apoptosis.
ODDI, Sergio   +3 more
core   +2 more sources

Endocannabinoids and related N-acylethanolamines: biological activities and metabolism

open access: yesInflammation and Regeneration, 2018
The plant Cannabis sativa contains cannabinoids represented by Δ9-tetrahydrocannabinol, which exert psychoactivity and immunomodulation through cannabinoid CB1 and CB2 receptors, respectively, in animal tissues. Arachidonoylethanolamide (also referred to
Kazuhito Tsuboi   +3 more
doaj   +1 more source

Anandamide and vanilloid TRPV1 receptors [PDF]

open access: yesBritish Journal of Pharmacology, 2003
A large body of evidence now exists to substantiate that the endocannabinoid, anandamide, activates TRPV1 receptors. It is a low intrinsic efficacy TRPV1 agonist that behaves as a partial agonist in tissues with a low receptor reserve, while in tissues with high receptor reserve and in circumstances associated with certain disease states, it behaves as
openaire   +2 more sources

Cannabinoid CB1 allosteric ligands suppress inflammatory pain in male mice without tolerance, motor impairment, memory deficits or respiratory depression

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 20, Page 6132-6153, October 2026.
Abstract Background and Purpose Positive allosteric modulators (PAMs) engage sites distinct from the orthosteric CB1 cannabinoid receptor binding site. GAT211, a racemic ligand, contains GAT228 (R) and GAT229 (S) enantiomers. Whether enantiomer‐mediated differences in allosteric activation or positive allosteric modulation translate into differences in
Ifeoluwa D. Solomon   +3 more
wiley   +1 more source

Molecular modeling of anandamide-cholesterol interactions.

open access: yes, 2013
A- Spacefill model of a cholesterol-anandamide complex in vacuo obtained with the Polak-Ribiere algorithm (for geometry optimization) and then submitted to Monte Carlo simulations.
Jacques Fantini (367498)   +3 more
core   +1 more source

Altered Anandamide Degradation in Attention Deficit Hyperactivity Disorder

open access: yesPediatric Neurology Briefs, 2009
Anandamide (AEA) metabolism was investigated in 15 drug-free boys with ADHD (aged 6.5-13 years) and 15 age- and gender-matched healthy controls, in a study at Universita Tor Vergata, Rome, Italy.
J Gordon Millichap
doaj   +1 more source

Pharmacological characterization of a novel, potent, selective, and orally active fatty acid amide hydrolase inhibitor, PKM‐833 [(R)‐N‐(pyridazin‐3‐yl)‐4‐(7‐(trifluoromethyl)chroman‐4‐yl)piperazine‐1‐carboxamide] in rats: Potential for the treatment of inflammatory pain

open access: yesPharmacology Research & Perspectives, 2020
Recently, we identified a novel fatty acid amide hydrolase (FAAH) inhibitor, PKM‐833 [(R)‐N‐(pyridazin‐3‐yl)‐4‐(7‐(trifluoromethyl)chroman‐4‐yl)piperazine‐1‐carboxamide].
Toshiya Endo   +2 more
doaj   +1 more source

Comparing the Impact of Tetrahydrocannabinol on 30‐Day Readmission Rates and Hospital Length of Stay in Patients With Depression

open access: yesBrain and Behavior, Volume 16, Issue 9, September 2026.
Among patients hospitalized for major depressive disorder, a positive THC urine drug screen was not independently associated with 30‐day psychiatric readmission or hospital length of stay. These findings suggest that patient factors beyond THC exposure may have a greater influence on hospitalization outcomes.
Mohammed E. Khedr   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy